LATEST
Sep 9, 2020
Gala Therapeutics’ RheOxTM System Showcased in Live Case at Virtual European Respiratory Society (ERS) Congress as Part of Post-Market Chronic Bronchitis Study
Menlo Park, CA, Sept. 9, 2020 – Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat pulmonary disease, today announced that a live case featuring its RheOxTM Bronchial Rheoplasty System was performed during the virtual European Respiratory Society (ERS)...